Written question asked by Lord Elliott of Ballinamallard (Ulster Unionist Party) on Thursday, 23 March 2017, in the House of Commons. It was due for an answer on Monday, 27 March 2017. It was answered by Baroness Blackwood of North Oxford (Conservative) on Thursday, 30 March 2017 on behalf of the Department of Health.
Familial Hypercholesterolaemia
- Question
-
To ask the Secretary of State for Health, if he will estimate the potential (a) medium and (b) long-term cost savings to the NHS of the use of genetic cascade testing to identify and treat familial hypercholesterolaemia.
- Answer
-
The current National Institute for Health and Care Excellence guidance recommends genetic cascade testing for familial hypercholesterolaemia as highly cost effective. This guidance is currently under review, due to be issued in May 2017, and will take into account the latest changes to the costs of drugs and genetic tests in its revised economic modelling.
Secondary information
- Type
- Written question
- Reference
- 68839
- Session
- 2016-17
- Subjects
- Costs Diagnosis Genetics Screening Familial hypercholesterolaemia
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2017-03-30 15:37:00 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/68839
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/68839
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/68839